Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo
- 1 January 1996
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 63 (S24), 269-275
- https://doi.org/10.1002/jcb.240630522
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Growth factor and peptide receptors in small cell lung cancerLife Sciences, 1993
- A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.Proceedings of the National Academy of Sciences, 1993
- A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone.Proceedings of the National Academy of Sciences, 1992
- Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumoursBritish Journal of Cancer, 1990
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.Journal of Clinical Investigation, 1989
- Signal transmission by the insulin-like growth factorsCell, 1989
- Production of insulin-like growth factor binding proteins by small-cell lung cancer cell linesExperimental Cell Research, 1989
- Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*Endocrine Reviews, 1989
- Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.Journal of Clinical Investigation, 1988
- Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cell linesExperimental Cell Research, 1988